Label Changes for:
Paxil (Paroxetine Hydrochloride) Tablets and Oral Suspension
Changes have been made to the CONTRAINDICATIONS, WARNINGS and PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
(Serotonin Toxicity associated with co-administration with Linezolid and Methylene Blue)